{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:48:26Z","timestamp":1791910106977,"version":"4.3.4"},"reference-count":89,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R278-2018-804"],"award-info":[{"award-number":["R278-2018-804"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbalip.2021.159063","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T05:47:18Z","timestamp":1634017638000},"page":"159063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease \u2013 Insights from randomized clinical trials and human genetics"],"prefix":"10.1016","volume":"1867","author":[{"given":"Emilie Westerlin","family":"Kjeldsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Qvist","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 8","key":"10.1016\/j.bbalip.2021.159063_bb0005","first-page":"9","article-title":"Studies on the lipid-protein relationship in normal and pathological sera and the effect of heparin on serum lipoproteins","volume":"5","author":"Nikkil\u00e4","year":"1953","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bbalip.2021.159063_bb0010","doi-asserted-by":"crossref","first-page":"732","DOI":"10.7326\/0003-4819-49-4-732","article-title":"Serum cholesterol, electrophoretic lipid pattern, diet and coronary artery disease: a study in coronary patients and in healthy men of different origin and occupations in Israel","volume":"49","author":"Brunner","year":"1958","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0015","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.CIR.22.6.1091","article-title":"Serum cholesterol and relative body weight of coronary patients in different populations","volume":"22","author":"Keys","year":"1960","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159063_bb0020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0002-9343(51)90183-0","article-title":"Protein-lipid relationships in human plasma: II. In atherosclerosis and related conditions","volume":"11","author":"Barr","year":"1951","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.0954-6820.1960.tb03562.x","article-title":"Serum lipids in men with myocardial infarction","volume":"167","author":"Carlson","year":"1960","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.bbalip.2021.159063_bb0030","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1172\/JCI103358","article-title":"A study of serum lipoproteins in normal and atherosclerotic patients by paper electrophoretic techniques","volume":"35","author":"Durrum","year":"1956","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159063_bb0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM197602052940601","article-title":"Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men","volume":"294","author":"Rhoads","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159063_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/clinchem\/hvaa148","article-title":"HDL in morbidity and mortality: a 40+ year perspective","volume":"67","author":"Tall","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbalip.2021.159063_bb0050","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2021.159063_bb0055","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of Torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0060","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of Dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0065","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0070","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of Anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Bowman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0080","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199011013231803","article-title":"Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation","volume":"323","author":"Inazu","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1126\/science.275.5298.391","article-title":"A mouse model with features of familial combined hyperlipidemia","volume":"275","author":"Masucci-Magoulas","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2021.159063_bb0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0095","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.jacc.2012.07.045","article-title":"Cholesteryl ester transfer protein and risk of ischemic cardiovascular disease","volume":"60","author":"Johannsen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2017.11467","article-title":"Association of genetic variants related to CETP inhibitors and statins with lipoprotein levels and cardiovascular risk","volume":"318","author":"Ference","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2021.159063_bb0105","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease","volume":"45","author":"Do","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2021.159063_bb0110","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomization study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2021.159063_bb0115","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0120","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.bbalip.2021.159063_bb0125","doi-asserted-by":"crossref","first-page":"E500","DOI":"10.1210\/jc.2010-0450","article-title":"Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease","volume":"95","author":"Haase","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2021.159063_bb0130","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1210\/jc.2011-1846","article-title":"LCAT, HDL cholesterol and ischemic heart disease \u2013 a mendelian randomization study of HDL cholesterol in 54,500 individuals","volume":"97","author":"Haase","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2021.159063_bb0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.atherosclerosis.2020.02.002","article-title":"Apolipoprotein A-I concentrations and risk of coronary artery disease: a Mendelian randomization study","volume":"299","author":"Karjalainen","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159063_bb0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2020.03.005","article-title":"HDL cholesterol and apolipoprotein A-I concentrations and risk of atherosclerotic cardiovascular disease: human genetics to unravel causality","volume":"299","author":"Frikke-Schmidt","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159063_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI","volume":"535","author":"Rubin","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2021.159063_bb0150","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2021.159063_bb0155","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jamacardio.2018.2121","volume":"3","author":"Nicholls","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0160","first-page":"806","article-title":"Effect of infusion of high-density lipoprotein mimetic containing recombinant apolipoprotein A-I Milano on coronary disease in patients with and acute coronary syndrome in the MILANO-PILOT Trial: a randomized clinical trial, JAMA Cardiol","volume":"3","author":"Nicholls","year":"2018"},{"key":"10.1016\/j.bbalip.2021.159063_bb0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jamacardio.2018.2168","article-title":"Apolipoprotein A-I infusion therapies for coronary disease: two outs in the ninth inning and swinging for the fences","volume":"3","author":"Rader","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias: from phenotype to genotype to management. A European Atherosclerosis Society Task Force Consensus Statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0175","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2021.159063_bb0180","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2016.08.038","article-title":"High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: the CANHEART study","volume":"68","author":"Ko","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0185","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/eurheartj\/ehx734","article-title":"High-density lipoprotein (HDL) and infections: a versatile culprit","volume":"39","author":"Speer","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159063_bb0190","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159063_bb0195","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2215\/CJN.00730116","article-title":"High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. veterans","volume":"11","author":"Bowe","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0200","doi-asserted-by":"crossref","unstructured":"Colijn JM, Verzijden T, Meester-Smoor MA, Klaver CCW, Colijn JM, Demirkan A, Verzijden T, Meester-Smoor MA, Ahmad S, Duijn CM van, Klaver CCW, Hollander AI den, Kersten E, Hoyng CB, Klaver CCW, Cougnard-Gr\u00e9goire A, Merle BBMJ, Korobelnik JFF, Delcourt C, Papageorgiou G, Mulder MT, Costa MA, Silva R, Benlian P, Bertelsen G, Bertelsen G, Bron AM, Creuzot-Garcher C, Claes B, Hense HW, Hoyng CB, Khawaja AP, Korobelnik JF, Piermarocchi S, Segato T, Silva R, Souied EH, Williams KM, van Duijn CM, Delcourt C, Klaver CCW, European Eye Epidemiology Consortium; EYE-RISK Consortium. Increased high-density lipoprotein levels associated with age-related macular degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia. Ophthalmology 2019;126:393\u2013406.","DOI":"10.1016\/j.ophtha.2018.09.045"},{"key":"10.1016\/j.bbalip.2021.159063_bb0205","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehx665","article-title":"U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies","volume":"39","author":"Madsen","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159063_bb0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/ATVBAHA.120.314050","article-title":"Novel insights from human studies on the role of high-density lipoprotein in mortality and noncardiovascular disease","volume":"41","author":"Madsen","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0215","article-title":"Plasma HDL cholesterol and risk of dementia \u2013 observational and genetic studies","author":"Kjeldsen","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbalip.2021.159063_bb0220","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.3390\/ijms22094547","article-title":"HDL cholesterol and non-cardiovascular disease: a narrative review","volume":"22","author":"Kjeldsen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbalip.2021.159063_bb0225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2021.159063_bb0230","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2021.159063_bb0235","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2021.159063_bb0240","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2009.06.005","article-title":"Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population","volume":"208","author":"Frikke-Schmidt","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbalip.2021.159063_bb0245","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.848143","article-title":"Functional lecithin:cholesterol acyltransferase is not required for efficient atheroprotection in humans","volume":"120","author":"Calabresi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159063_bb0250","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCULATIONAHA.105.540427","article-title":"Compromised LCAT function is associated with increased atherosclerosis","volume":"112","author":"Hovingh","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159063_bb0255","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jalz.2015.04.006","article-title":"A loss-of-function mutation in ABCA1 and risk of Alzheimer disease and cerebrovascular disease","volume":"11","author":"Nordestgaard","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbalip.2021.159063_bb0260","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/CIRCULATIONAHA.118.034706","article-title":"Complete and partial lecithin:cholesterol acyltransferase deficiency is differentially associated with atherosclerosis","volume":"138","author":"Oldoni","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159063_bb0265","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","article-title":"Genetic variant of the scavenger receptor BI in humans","volume":"365","author":"Vergeer","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-0004.2011.01682.x","article-title":"Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans","volume":"779","author":"Brunham","year":"2011","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbalip.2021.159063_bb0275","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrcardio.2017.78","article-title":"Mendelian randomization in cardiometabolic disease: challenges in evaluating causality","volume":"14","author":"Holmes","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0280","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-020-00493-1","article-title":"Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development","volume":"18","author":"Holmes","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0285","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analysis with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.bbalip.2021.159063_bb0295","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2021.159063_bb0300","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/s41467-019-10679-y","article-title":"Mendelian randomization analysis of the effect of educational attainment and cognitive ability on smoking behaviour","volume":"10","author":"Sanderson","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbalip.2021.159063_bb0305","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ije\/dyy262","article-title":"An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings","volume":"48","author":"Sanderson","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0310","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1002\/sim.7492","article-title":"Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and ummeasured pleiotropy","volume":"36","author":"Rees","year":"2017","journal-title":"Stat. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0315","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Nonfasting remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0325","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement fromthe European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159063_bb0330","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159063_bb0335","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.P120001000","article-title":"Lipid and metabolic syndrome traits in coronary artery disease: a Mendelian randomization study","volume":"62","author":"Thomas","year":"2021","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159063_bb0340","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"J\u00f8rgensen","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0345","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2021.159063_bb0350","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehs431","article-title":"Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction","volume":"34","author":"J\u00f8rgensen","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159063_bb0355","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.11.3.569","article-title":"Quantitative studies of transfer in vivo of low density, sf 12-60, and sf 60-400 lipoprotiens between plasma and arterial intima in humans","volume":"11","author":"Shaikh","year":"1991","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.bbalip.2021.159063_bb0360","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.ATV.15.4.534","article-title":"Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo: molecular size as a determinant of fractional loss from the intima-inner media","volume":"vol. 15","author":"Nordestgaard","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0365","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/01.ATV.12.1.6","article-title":"Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentration, extent of aortic lesion, and lipoprotein particle size as determinants","volume":"12","author":"Nordestgaard","year":"1992","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.bbalip.2021.159063_bb0370","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st century: a multifunctional roadmap for future HDL research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159063_bb0375","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98045","article-title":"Apolipoprotein E and CIII interact to regulate HDL metabolism and coronary heart disease risk","volume":"3","author":"Morton","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbalip.2021.159063_bb0380","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/ATVBAHA.120.314609","article-title":"Protein-defined subspecies of HDLs (high-density lipoproteins) and differential risk of coronary heart disease in 4 prospective studies","volume":"40","author":"Sacks","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0385","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nsmb.3501","article-title":"A consensus model of human apolipoprotein A-I in its monomeric and lipid-free state","volume":"24","author":"Melchior","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0390","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithin.cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2021.159063_bb0395","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.bbalip.2021.159063_bb0400","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.180.4093.1332","article-title":"Atherosclerosis and the arterial smooth muscle cell","volume":"180","author":"Ross","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.bbalip.2021.159063_bb0405","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","article-title":"Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease","volume":"1","author":"Miller","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.bbalip.2021.159063_bb0410","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1172\/JCI200523915","article-title":"Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of ApoA-I","volume":"115","author":"Timmins","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159063_bb0415","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI27352","article-title":"Intestinal ABCA1 directly contributes to HDL biogenesis in vivo","volume":"116","author":"Brunham","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2021.159063_bb0420","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2021.159063_bb0425","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/ATVBAHA.118.311366","article-title":"Cholesterol mass efflux capacity incident cardiovascular disease, and progression of carotid plaque","volume":"39","author":"Shea","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0430","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2021.159063_bb0435","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S2213-8587(19)30003-8","article-title":"Rethinking good cholesterol: a clinicians\u2019s guide to understanding HDL","volume":"7","author":"Xiang","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbalip.2021.159063_bb0440","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ophtha.2017.03.042","article-title":"Mendelian randomization implicates high-density lipoprotein cholesterol-associated mechanisms in etiology of age-related macular degeneration","volume":"124","author":"Burgess","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bbalip.2021.159063_bb0445","article-title":"New insights on the genetic etiology of Alzheimer\u2019s and related dementias","author":"Bellenguez","year":"2020","journal-title":"MedRxiv"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198121001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198121001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:13:34Z","timestamp":1761387214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198121001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":89,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1388198121001918"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2021.159063","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease \u2013 Insights from randomized clinical trials and human genetics","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2021.159063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"159063"}}